Behavioral problems in Duchenne muscular dystrophy: how do we manage them in clinical practice?

被引:0
|
作者
Geuens, S. [1 ]
Verly, M. [2 ]
Lemiere, J. [1 ]
Goemans, N. [1 ]
De Waele, L. [1 ]
机构
[1] UZ Leuven, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven, Belgium
关键词
D O I
10.1016/j.nmd.2019.06.477
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EP.71
引用
收藏
页码:S173 / S173
页数:1
相关论文
共 50 条
  • [41] Practical problems and management of seating through the clinical stages of Duchenne's muscular dystrophy
    Liu, MG
    Mineo, K
    Hanayama, K
    Fujiwara, T
    Chino, N
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (06): : 818 - 824
  • [42] Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice
    Rodriguez-Cruz, Maricela
    Almeida-Becerril, Tomas
    Atilano-Miguel, Salvador
    Cardenas-Conejo, Alan
    Bernabe-Garcia, Mariela
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2020, 99 (12) : 1121 - 1128
  • [43] How Do Primary Care Pediatricians Manage Behavioral Health Problems?
    Cook, Andrew
    Lancaster, Blake
    Bruni, Teryn
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2017, 38 (02): : S6 - S6
  • [44] Difficulties in ESWL and how we manage them
    不详
    JOURNAL OF ENDOUROLOGY, 2004, 18 : A155 - A155
  • [45] How do fine and gross motor skills develop in preschool boys with Duchenne Muscular Dystrophy?
    Hoskens, Jasmine
    Vandekerckhove, Ines
    De Waele, Liesbeth
    Feys, Hilde
    Goemans, Nathalie
    Klingels, Katrijn
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2024, 154
  • [46] Safety and clinical outcome of tamoxifen in Duchenne muscular dystrophy
    Tsabari, Reuven
    Simchovitz, Elana
    Lavi, Eran
    Eliav, Osnat
    Avrahami, Ran
    Ben-Sasson, Shmuel
    Dor, Talya
    NEUROMUSCULAR DISORDERS, 2021, 31 (09) : 803 - 813
  • [47] Clinical potential of ataluren in the treatment of Duchenne muscular dystrophy
    Namgoong, John Hyun
    Bertoni, Carmen
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2016, 6 : 37 - 48
  • [48] Clinical management of Duchenne muscular dystrophy: the state of the art
    Sonia Messina
    Gian Luca Vita
    Neurological Sciences, 2018, 39 : 1837 - 1845
  • [49] Biomarker panel for Duchenne muscular dystrophy clinical trials
    Tsioutsias, I.
    Bautista, A.
    Terrill, J.
    Bakker, A.
    Pinniger, G.
    Arthur, P.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [50] Epidemiological evaluation of clinical history in Duchenne muscular dystrophy
    Martinelli, F
    Felisari, G
    Turconi, A
    Comi, GP
    Robotti, M
    Ausenda, CD
    Scarlato, G
    Bresolin, N
    NEUROLOGY, 1997, 48 (03) : 5040 - 5040